Thyroid Cancer Diagnostics Market: Introduction

  • Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. A normal thyroid gland produces around 80% T4 and 20% T3. The thyroid gland is prone to several issues including underactive thyroid (hypothyroidism), overactive thyroid (hyperthyroidism), and thyroid nodules, autoimmune thyroiditis (Hashimoto’s thyroiditis), and papillary thyroid carcinoma.
  • Thyroid cancer is a form of malignant cancer that is initiated from the parfollicular and follicular thyroid cells. Treatments available for thyroid cancer are the surgical removal of the thyroid gland, radioactive ablation, and thyroid stimulating hormone (TSH) suppression therapy.
  • Papillary thyroid carcinoma is a highly common form of thyroid cancer and constitutes about 80% of all thyroid cancers detected. Papillary thyroid carcinomas are well-differentiated tumors that can largely remain asymptomatic in early stages and are marked by only a mass or lump in the neck. Papillary thyroid cancer has high survival rate, better prognosis, and can usually be cured in most cases, unlike rare anaplastic thyroid cancer that grows and spreads quickly and has lesser chance of recovery.
  • Follicular thyroid cancer accounts for 10% to 15% of all thyroid cancers. It occurs more often in women and older patients with a female-to-male ratio of 3:1 and a mean age of 60 years at the time of diagnosis. According to the American Society of Clinical Oncology (ASCO), an estimated 52,070 adults (14,260 men and 37,810 women) in the U.S. were diagnosed with thyroid cancer in 2019. Thus, a rise in cases of follicular thyroid cancer is propelling the thyroid cancer diagnostics market.

Request a sample to get extensive insights into the Thyroid Cancer Diagnostics Market

Key Drivers and Restraints of Global Thyroid Cancer Diagnostics Market

  • The global thyroid cancer diagnostics market is driven by an increase in incidence of thyroid disorders such as hypothyroidism and hyperthyroidism. Rise in the number of patients affected with autoimmune diseases (which is a major risk factor for thyroid disorder). For instance, Grave’s disease is considered as a major factor for consistent increase in incidence of thyroid disorders, including cancer. Additionally, prevalence of thyroid cancer is increasing at a consistent rate in developed countries. This boosts the global thyroid cancer diagnostic market.
  • Organizations such as the World Health Organization (WHO) and the American Association of Clinical Endocrinologists (AACE) have stated that thyroid disorders are rapidly increasing and demand novel and effective thyroid therapeutics for treatment
  • Age, gender, and exposure to harmful radiations are major risk factors for developing thyroid cancer
  • Several private and government organizations and key companies are engaged in increasing awareness about thyroid disorders through disorder awareness campaigns in developing as well as developed regions. These programs would increase awareness about thyroid cancer among the patient population, leading to higher rate of adoption of thyroid therapeutics.

Asia Pacific to Lead Global Thyroid Cancer Diagnostics Market

  • In terms of region, the global thyroid cancer diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global follicular thyroid cancer diagnostics market in 2019. It is expected to maintain its dominance during the forecast period. This is due to an increase in the demand for minimally invasive treatments and increase in focus on patient safety as well as advancement in technologies and established distribution channels.
  • However, the market in Asia Pacific is projected to expand at a prominent growth rate during the forecast period owing to an increase in healthcare expenditure and improvement in healthcare facilities

To understand how our report can bring difference to your business strategy, Ask for a brochure

Key Players Operating in Global Thyroid Cancer Diagnostics Market

The global thyroid cancer diagnostics market is fragmented, with the presence of large number of small-scale and large-scale companies

Leading companies operating in the global thyroid cancer diagnostics market are:

  • Abbott Laboratories
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holding Corporation
  • Leica Biosystems Nussloch GmbH
  • Toshiba Corporation
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Siemens Healthineers
  • GE Healthcare
  • Hologic, Inc.
  • Bio-Rad Laboratories, Inc

Global Thyroid Cancer Diagnostics Market: Research Scope

Global Thyroid Cancer Diagnostics Market, by Technique

  • Imaging
  • Tissue Biopsy Tests
  • Molecular Testing
  • Others

Global Thyroid Cancer Diagnostics Market, by Type

  • Papillary Thyroid Carcinoma
  • Follicular Thyroid Carcinoma
  • Others

Global Thyroid Cancer Diagnostics Market, by End-user

  • Hospitals & Ambulatory Surgery Centers
  • Diagnostic Laboratories
  • Research & Academic Institutes
  • Others

This upcoming business intelligence report is intended to be a one-stop market research solution to guide organizations in taking timely and effective decisions for their business growth. The ongoing study is the culmination of our deep expertise on data science methods, combined with an unparalleled understanding of the external environment and analysis of the industries. Each of the reports by TMR aims at offering a detailed scrutiny of the value chain of our current and prospective customers, takes them from identifying value propositions, and subsequently assist their business executives to implement right strategies to create customer value. We believe that creating and sustaining the customer value is the key pivot on which business executives can create profits for their organizations and increase the market shares, continuously and with sustainability.

Each of our touchpoints through which we engage with the organization/enterprise during the primary research enables us to understand the internal environment it operates in and the ways in which the external environment influences its growth.

Always Evolving with Competition

Excellence is built into the DNA of TMR, and all our teams work collaboratively and committedly toward achieving that in whatever they do. From the very first interaction our teams of research analysts have with any interested market participant to the final preparation processes in each of our reports reflects a rigorous understanding of the dynamic industry environment that businesses operate in.

We relentlessly work to be a differentiator in whatever we do in the current era of hypercompetitive global environment. The result of our unceasing focus on excellence is reflected clearly in the insights and guidance we offer to our customers in order to empower them to create brand equity. Our simple yet very powerful underpinning for navigating the competition is to always keep evolving with changing business environments. Our close-kinit team of research analysts not only believe in this simple philosophy but also implement the same.

Constantly Innovating Our Research Methodologies and Models

We do not limit with any specific market research tool or one standard approach for obtaining or analyzing data. Undoubtedly, our report making process is ever-evolving to meet the customer needs and demands supported broadly by a vast knowledge of data science methods that we combine with business acumen our teams have built upon for several years. Evidently, our primary and secondary research data about customers and consumers have shown that we can go to any lengths to obtain them. This is followed by applying next-gen automation tools integrated with human judgement to clear the clutter, ascertain the most relevant and recent qualitative and quantitative insights, and package them in digestible chunks in our reports for our customers.

We Take Pride in No-One-Size-Fits-All Approach

Over the past several years, we have been conducting market intelligence studies across all industries for all types of organizations — big and small, profit and not-for-profit, and Fortune 500 and Unicorns, as we believe that a sound decision making must be based on no-one-size-fits-all approach. Without doubt, each of the organizations regardless of the industry they are in are affected differently by changes in political, economic, socio-culture, legal, ecological, and legal environments. The research models and the value chain analysis process that our analysts employ for conducting the study uphold this approach.

We look at myriad components of internal and external business environment affecting the growth strategies of organizations. Some of the broader aspects that we focus on are:

  • Our team of Analysts and Support Teams always strive to see the bigger picture in life cycle stages of any industry
  • The Teams focus on obtaining valuable insights into different models of competitive advantage while making an internal environment analysis
  • They keep on modifying the value chain analysis processes of organizations to understand on how customer value is created

Some areas of assessing market dynamics that are used in the research models and methodologies adopted by our analysts can be summarized as:

  • Corporate and business strategies underlying new brand positioning strategies
  • Mapping for strategic planning for business units
  • Various metrics for business portfolio analysis, including BCG matrix
  • Value chain analysis

These will help create and sustain competitive advantage for our prospects and current customers.

Key focus areas and agenda that underpin and catalyze our primary and secondary research initiatives and endeavors are:

  • What are some of the core competencies and distinctive competencies of new entrants and established players in the industry we are analyzing?
  • What are some of the branding opportunities that are emerging at a rapid pace?
  • What are the major competitive forces and elements of external environment shaping the industry life cycle stages of most organizations?
  • Why some competitive strategies are popular than others among leaders in a certain market?
  • What customer-based brand equity strategies companies have leveraged in a certain industry or set of related industries in a sector?
  • What are some of the key pricing strategies that companies in an industry are implementing for marketing their products internationally?
  • Identifying whether market-push or market-pull strategies are more relevant to a certain product or a service?

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Thyroid Cancer Diagnostics Market